Related Experiment Video
Updated: May 21, 2026
Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Peripheral nerve sheath tumors-on-a-chip: Next-generation platforms for mechanistic and therapeutic studies
William H Delaney1, Sara A Faulkner2,3,4,5,6, Wilbur A Lam2,3,4,5,6
1Department of Neurosurgery, Emory University School of Medicine, Atlanta, GA, USA.
Abstract:
Recapitulation of the complex nerve-tumor-immune microenvironment is critical for understanding Peripheral Nerve Sheath Tumors (PNSTs). Conventional in vitro models and animal systems often struggle to model crucial intercellular and inter-organ communication with full physiological relevance, creating a bottleneck in discovering effective therapeutics. Organ-on-Chip (OoC) technologies offer a paradigm-shifting solution. These microengineered platforms precisely integrate human cell biology with controllable fluidic and mechanical cues to replicate tissue- and organ-level physiology, enabling real-time, quantitative monitoring of tissue dynamics. This review posits that OoC technology is poised to revolutionize PNST research. In this review, we summarize the development of advanced Tumor-Nerve-Immune-on-Chip systems that integrate patient-derived Schwann cells, immune components, and functional microvasculature. These systems will accurately model PNSTs. Adoption of OoC will enable a predictive and individualized experimental framework, accelerating therapeutic discovery and allowing for personalized drug prediction for these challenging diseases.
Insights
Organ-on-Chip technology revolutionizes Peripheral Nerve Sheath Tumor (PNST) research by accurately modeling the complex tumor-nerve-immune microenvironment. This approach accelerates the discovery of personalized therapeutics for challenging PNSTs.
Area of Science:
- Biomedical Engineering
- Oncology
- Neuroscience
Background:
- Peripheral Nerve Sheath Tumors (PNSTs) require complex models of the nerve-tumor-immune microenvironment.
- Current in vitro and animal models lack physiological relevance for intercellular and inter-organ communication.
- This limits the discovery of effective PNST therapeutics.
Purpose of the Study:
- To review the development of advanced Organ-on-Chip (OoC) systems for modeling PNSTs.
- To highlight the potential of OoC technology in revolutionizing PNST research.
- To emphasize the role of OoC in accelerating therapeutic discovery and personalized medicine for PNSTs.
Main Methods:
- Development of microengineered platforms integrating human cells with fluidic and mechanical cues.
- Creation of Tumor-Nerve-Immune-on-Chip systems using patient-derived Schwann cells, immune components, and microvasculature.
- Real-time, quantitative monitoring of tissue dynamics within OoC platforms.
Main Results:
- Advanced OoC systems accurately recapitulate the PNST microenvironment.
- These systems enable precise integration of cellular and physiological cues.
- OoC platforms facilitate real-time monitoring of complex biological interactions.
Conclusions:
- Organ-on-Chip technology offers a paradigm shift for PNST research.
- OoC adoption enables a predictive and individualized experimental framework.
- This technology accelerates therapeutic discovery and personalized drug prediction for PNSTs.
